Stoke Therapeutics (0GT) Revenue

0 Followers

Stoke Therapeutics Revenue

Stoke Therapeutics had a revenue of 9.32M in the quarter ending Jun 30, 2026, with 49.70%. This bring the company's revenue in the last twelve months to 27.59M, Increased -14.00%. In the fiscal year ending Dec 31, 2025, Stoke Therapeutics had annual revenue of 184.42M with 404.50% growth.

Revenue (ttm)

27.59M

Revenue Growth

-87.46%

P/S Ratio

8.66

Revenue/Employee

€1,084,824

Employees

170

Market Cap

€1.60B

Revenue Chart

Revenue History

Fiscal End Date	Revenue	Change	Growth
Dec 31, 2025	184.42M	147.87M	+404.50%
Dec 31, 2024	36.55M	27.77M	+316.34%
Dec 31, 2023	8.78M	-3.63M	-29.22%
Dec 31, 2022	12.40M	―	+∞%
Dec 31, 2021	―	―	―
Dec 31, 2020	―	―	―
Dec 31, 2019	―	―	―
Dec 31, 2018	―	―	―
Dec 31, 2017	―	―	―